Zheng Shi

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 8

Top Topics

Top Venues

Briefings in bioinformatics

Reviews in endocrine & metabolic disorders

Purinergic signalling

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Liu, Hanlin Li, Tianyu Zeng, Yang Wang, Hongqi Zhang, Ying Wan, Zheng Shi, Renzhi Cao, Hua Tang
Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning. Briefings in bioinformatics 25 (1) (2024)
Yang Liu, Hanlin Li, Tianyu Zeng, Yang Wang, Hongqi Zhang, Ying Wan, Zheng Shi, Renzhi Cao, Hua Tang
Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning. Briefings in bioinformatics 25 (1) (2024)
Yang Liu, Hanlin Li, Tianyu Zeng, Yang Wang, Hongqi Zhang, Ying Wan, Zheng Shi, Renzhi Cao, Hua Tang
Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning. Briefings in bioinformatics 25 (1) (2024)
Amin Ullah, Ahmad Ud Din, Wen Ding, Zheng Shi, Ying-Xiong Wang, Bai-Rong Shen
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Reviews in endocrine & metabolic disorders (2023)
Amin Ullah, Ahmad Ud Din, Wen Ding, Zheng Shi, Ying-Xiong Wang, Bai-Rong Shen
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Reviews in endocrine & metabolic disorders (2023)
Amin Ullah, Ahmad Ud Din, Wen Ding, Zheng Shi, Ying-Xiong Wang, Bai-Rong Shen
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Reviews in endocrine & metabolic disorders (2023)
Guangya Xu, Shutao Zhang, Lulu Zheng, Zhongjiao Hu, Lijia Cheng, Lvlin Chen, Jun Li, Zheng Shi
In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations. Purinergic signalling (2021)
Tian Yu, Xiaoheng Guo, Zhen Zhang, Rong Liu, Liang Zou, Jia Fu, Zheng Shi
Meta-Analysis of the Clinical Effectiveness and Safety of Ligustrazine in Cerebral Infarction. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)